On Station

News and Views from the International Space Station U.S. National Laboratory.

Feb 28, 2017

Upward Volume 2, Issue 1 – the quarterly magazine of the ISS National Lab

Feb 17, 2017

Bacteria Research and More Slated for SpaceX CRS-10

Sep 27, 2016

Upward Issue 3 – the quarterly magazine of the ISS National Lab

Find out how Procter & Gamble (P&G), an innovation giant among consumer goods companies, is utilizing the unique environment of space to improve the customer experience on Earth and learn how a new molecular biology tool onboard the ISS National Lab, called WetLab-2, is helping to transform the ISS into a state-of-the-art biological laboratory.

Read more

Jul 21, 2016

Superheroes, Celebrities and the Space Station to Highlight Comic-Con San Diego 2016

July has been an exciting month for the ISS National Laboratory and the CASIS team supporting two important events—the ISS R&D Conference, which brought together researchers, thought leaders, and new users to talk about the space station, new results, and expanding research capabilities in space; and the SpaceX-9 re-supply mission launch, which delivered more than 20 National Lab research payloads that will contribute to a bevy of scientific investigations. CASIS outreach team is setting its sights on another exciting opportunity to communicate the importance of the ISS National Laboratory to a new community—Comic-Con San Diego!Read more

Jul 20, 2016

SpaceX CRS-9: Major Payloads Sponsored by the ISS U.S. National Laboratory

Jul 14, 2016

CASIS Releases Final Report on Microgravity Protein Crystal Growth Workshop

For more than 30 years, microgravity has been used to improve outcomes of crystal analyses through production of higher quality and larger crystals. Many crystals grown in microgravity are larger and more detailed than those grown on Earth, providing protein structures that are more accurate. This allows better structure-based drug designs while also informing improved strategies for drug manufacturing—with the end goal of more effective and affordable pharmaceuticals.Read more
1 2 3 4 5 6 7 8 9 10 Last